Praxis biotech invests in companies in the fast growing market of biotechnology and companies with late stage preclinical or early stage clinical therapeutic assets with particular attention to metabolic disease, oncology, and infectious disease. Praxis biotech has the flexibility to deploy part-time or full-time expertise for each investment based on the unique requirements of the project. Partners at Praxis biotech directly invest in our portfolio companies and also have strong connections to other sources of capital and enable rapid follow on financings or entry into the public markets.
DISCLAIMER: We do not own or advertise any of the Investment Programs you can find on this website. The information presented above is based on statistics and personal experience only - its authenticity is not warranted. Please bear in mind that all HYIPs investments presuppose high risks. We do not recommend you to waste what you cannot afford to lose..